KEGG   PATHWAY: mpah05330
Entry
mpah05330                   Pathway                                
Name
Allograft rejection - Mus pahari (shrew mouse)
Description
Allograft rejection is the consequence of the recipient's alloimmune response to nonself antigens expressed by donor tissues. After transplantation of organ allografts, there are two pathways of antigen presentation. In the direct pathway, recipient T cells react to intact allogeneic MHC molecules expressed on the surface of donor cells. This pathway would activate host CD4 or CD8 T cells. In contrast, donor MHC molecules (and all other proteins) shed from the graft can be taken up by host APCs and presented to recipient T cells in the context of self-MHC molecules - the indirect pathway. Such presentation activates predominantly CD4 T cells. A direct cytotoxic T-cell attack on graft cells can be made only by T cells that recognize the graft MHC molecules directly. Nontheless, T cells with indirect allospecificity can contribute to graft rejection by activating macrophages, which cause tissue injury and fibrosis, and are also likely to be important in the development of an alloantibody response to graft.
Class
Human Diseases; Immune disease
Pathway map
mpah05330  Allograft rejection
mpah05330

Organism
Mus pahari (shrew mouse) [GN:mpah]
Gene
110314816  HLA class I histocompatibility antigen, A-25 alpha chain-like isoform X1 [KO:K06751]
110314822  H-2 class I histocompatibility antigen, D-37 alpha chain-like [KO:K06751]
110314930  HLA class I histocompatibility antigen, A-25 alpha chain-like [KO:K06751]
110314994  LOW QUALITY PROTEIN: H-2 class I histocompatibility antigen, alpha chain-like [KO:K06751]
110335754  HLA class I histocompatibility antigen, A-24 alpha chain-like [KO:K06751]
110335755  LOW QUALITY PROTEIN: HLA class I histocompatibility antigen, A-24 alpha chain-like [KO:K06751]
110335756  class I histocompatibility antigen, Gogo-B*0101 alpha chain-like [KO:K06751]
110315033  H-2 class I histocompatibility antigen, Q10 alpha chain-like [KO:K06751]
110315071  HLA class I histocompatibility antigen, A-25 alpha chain-like [KO:K06751]
110335839  H-2 class I histocompatibility antigen, D-B alpha chain-like isoform X1 [KO:K06751]
110335840  H-2 class I histocompatibility antigen, D-37 alpha chain-like [KO:K06751]
110335841  class I histocompatibility antigen, Non-RT1.A alpha-1 chain-like [KO:K06751]
110315143  HLA class I histocompatibility antigen, A-25 alpha chain-like [KO:K06751]
110315275  H-2 class I histocompatibility antigen, Q9 alpha chain-like [KO:K06751]
110315312  HLA class I histocompatibility antigen, A-32 alpha chain-like [KO:K06751]
110335989  H-2 class I histocompatibility antigen, Q9 alpha chain-like [KO:K06751]
110336005  HLA class I histocompatibility antigen, B-14 alpha chain-like [KO:K06751]
110336006  H-2 class I histocompatibility antigen, Q10 alpha chain-like [KO:K06751]
110336017  HLA class I histocompatibility antigen, alpha chain G-like [KO:K06751]
110315373  HLA class I histocompatibility antigen, A-24 alpha chain-like [KO:K06751]
110336104  LOW QUALITY PROTEIN: H-2 class I histocompatibility antigen, D-B alpha chain-like [KO:K06751]
110315457  class I histocompatibility antigen, Gogo-A*0501 alpha chain-like [KO:K06751]
110315468  class I histocompatibility antigen, Gogo-B*0103 alpha chain-like [KO:K06751]
110315518  H-2 class I histocompatibility antigen, Q10 alpha chain-like [KO:K06751]
110314674  patr class I histocompatibility antigen, A-2 alpha chain-like [KO:K06751]
110314692  H-2 class I histocompatibility antigen, Q7 alpha chain-like isoform X1 [KO:K06751]
110316786  uncharacterized protein LOC110316786 [KO:K10785]
110329945  Cd80; T-lymphocyte activation antigen CD80 [KO:K05412]
110330066  Cd86; T-lymphocyte activation antigen CD86 [KO:K05413]
110322470  Cd28; T-cell-specific surface glycoprotein CD28 [KO:K06470]
110320680  Il12a; interleukin-12 subunit alpha [KO:K05406]
110332403  Il12b; interleukin-12 subunit beta [KO:K05425]
110322215  Faslg; tumor necrosis factor ligand superfamily member 6 isoform X1 [KO:K04389]
110332797  Fas; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
110327029  Prf1; perforin-1 [KO:K07818]
110325862  mast cell protease 8 [KO:K01353] [EC:3.4.21.79]
110325528  granzyme B(G,H) [KO:K01353] [EC:3.4.21.79]
110325544  granzyme C [KO:K01353] [EC:3.4.21.79]
110335630  class II histocompatibility antigen, M alpha chain [KO:K06752]
110335686  HLA class II histocompatibility antigen, DO beta chain isoform X1 [KO:K06752]
110335782  H-2 class II histocompatibility antigen, E-K alpha chain [KO:K06752]
110335853  HLA class II histocompatibility antigen, DO alpha chain [KO:K06752]
110335947  RLA class II histocompatibility antigen, DP alpha-1 chain [KO:K06752]
110335433  H-2 class II histocompatibility antigen, A-S beta chain [KO:K06752]
110335519  H-2 class II histocompatibility antigen, I-E beta chain [KO:K06752]
110335565  H-2 class II histocompatibility antigen, A-B alpha chain [KO:K06752]
110335584  H-2 class II histocompatibility antigen, I-E beta chain-like [KO:K06752]
110320556  Il2; interleukin-2 [KO:K05429]
110314146  Cd40lg; CD40 ligand [KO:K03161]
110318846  Cd40; tumor necrosis factor receptor superfamily member 5 isoform X1 [KO:K03160]
110326932  Ifng; interferon gamma [KO:K04687]
110335791  Tnf; tumor necrosis factor isoform X1 [KO:K03156]
110332760  Il4; interleukin-4 [KO:K05430]
110332614  Il5; interleukin-5 [KO:K05428]
110322547  Il10; interleukin-10 [KO:K05443]
Compound
C00533  Nitric oxide
Reference
  Authors
Arakelov A, Lakkis FG.
  Title
The alloimmune response and effector mechanisms of allograft rejection.
  Journal
Semin Nephrol 20:95-102 (2000)
Reference
  Authors
Le Moine A, Goldman M, Abramowicz D.
  Title
Multiple pathways to allograft rejection.
  Journal
Transplantation 73:1373-81 (2002)
DOI:10.1097/00007890-200205150-00001
Reference
  Authors
Trivedi HL.
  Title
Immunobiology of rejection and adaptation.
  Journal
Transplant Proc 39:647-52 (2007)
DOI:10.1016/j.transproceed.2007.01.047
Reference
  Authors
Pietra BA.
  Title
Transplantation immunology 2003: simplified approach.
  Journal
Pediatr Clin North Am 50:1233-59 (2003)
DOI:10.1016/S0031-3955(03)00119-6
Reference
PMID:8835634
  Authors
Oka T, Yoshimura N.
  Title
Immunosuppression in organ transplantation.
  Journal
Jpn J Pharmacol 71:89-100 (1996)
DOI:10.1254/jjp.71.89
Reference
  Authors
Sayegh MH.
  Title
Why do we reject a graft? Role of indirect allorecognition in graft rejection.
  Journal
Kidney Int 56:1967-79 (1999)
DOI:10.1046/j.1523-1755.1999.00751.x
Reference
  Authors
Benichou G.
  Title
Direct and indirect antigen recognition: the pathways to allograft immune rejection.
  Journal
Front Biosci 4:D476-80 (1999)
DOI:10.2741/benichou
Reference
  Authors
Turvey SE, Wood KJ.
  Title
Immunobiology of solid organ transplantation.
  Journal
Int Surg 84:279-90 (1999)
Reference
  Authors
Janeway CA, Travers P, Walport M, Shlomchik MJ.
  Title
Immunobiology 6th edition
  Journal
Garland Science Publishing (2005)
Reference
  Authors
Game DS, Lechler RI.
  Title
Pathways of allorecognition: implications for transplantation tolerance.
  Journal
Transpl Immunol 10:101-8 (2002)
DOI:10.1016/S0966-3274(02)00055-2
Reference
  Authors
Lechler RI, Garden OA, Turka LA.
  Title
The complementary roles of deletion and regulation in transplantation tolerance.
  Journal
Nat Rev Immunol 3:147-58 (2003)
DOI:10.1038/nri1002
Related
pathway
mpah04210  Apoptosis
mpah04514  Cell adhesion molecules
mpah04610  Complement and coagulation cascades
mpah04612  Antigen processing and presentation
mpah04660  T cell receptor signaling pathway
mpah04662  B cell receptor signaling pathway
KO pathway
ko05330   
LinkDB

DBGET integrated database retrieval system